Browse > Article
http://dx.doi.org/10.5808/GI.2009.7.2.122

Integrative Analysis of Microarray Data with Gene Ontology to Select Perturbed Molecular Functions using Gene Ontology Functional Code  

Kim, Chang-Sik (Department of Biological Sciences, Sookmyung Women's University)
Choi, Ji-Won (Department of Biological Sciences, Sookmyung Women's University)
Yoon, Suk-Joon (Department of Biological Sciences, Sookmyung Women's University)
Publication Information
Genomics & Informatics / v.7, no.2, 2009 , pp. 122-130 More about this Journal
Abstract
A systems biology approach for the identification of perturbed molecular functions is required to understand the complex progressive disease such as breast cancer. In this study, we analyze the microarray data with Gene Ontology terms of molecular functions to select perturbed molecular functional modules in breast cancer tissues based on the definition of Gene ontology Functional Code. The Gene Ontology is three structured vocabularies describing genes and its products in terms of their associated biological processes, cellular components and molecular functions. The Gene Ontology is hierarchically classified as a directed acyclic graph. However, it is difficult to visualize Gene Ontology as a directed tree since a Gene Ontology term may have more than one parent by providing multiple paths from the root. Therefore, we applied the definition of Gene Ontology codes by defining one or more GO code(s) to each GO term to visualize the hierarchical classification of GO terms as a network. The selected molecular functions could be considered as perturbed molecular functional modules that putatively contributes to the progression of disease. We evaluated the method by analyzing microarray dataset of breast cancer tissues; i.e., normal and invasive breast cancer tissues. Based on the integration approach, we selected several interesting perturbed molecular functions that are implicated in the progression of breast cancers. Moreover, these selected molecular functions include several known breast cancer-related genes. It is concluded from this study that the present strategy is capable of selecting perturbed molecular functions that putatively play roles in the progression of diseases and provides an improved interpretability of GO terms based on the definition of Gene Ontology codes.
Keywords
breast cancer; gene ontology code; gene ontology functional code; microarray; molecular functions;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee, S.G., Hur, J.U., and Kim, Y.S. (2004). A graph-theoretic modeling on GO space for biological interpretation of gene clusters. Bioinformatics 20, 381-388   DOI   ScienceOn
2 Reis-Filho, J.S., Steele, D., Di Palma, S., Jones, R.L., Savage, K., James, M., Milanezi, F., Schmitt, F.C., and Ashworth, A. (2006). Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod. Pathol. 19, 307-319   DOI   ScienceOn
3 Wang, Z., Shen, D., Parsons, D.W., et al. (2004). Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304, 1164-1166   DOI   PUBMED   ScienceOn
4 Yang, Z.Q., Streicher, K.L., Ray, M.E., Abrams, J., and Ethier, S.P. (2006). Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 66, 11632-11643   DOI   ScienceOn
5 Amirkhosravi, A., Meyer, T., Warnes, G., Amaya, M., Malik, Z., Biggerstaff, J.P., Siddiqui, F.A., Sherman, P., and Francis, J.L. (1998). Pentoxifylline Inhibits Hypoxia-induced Upregulation of Tumor Cell Tissue Factor and Vascular Endothelial Growth Factor. Thromb . Haemost . 4, 598-602
6 Benhaj, K., Akcali, K.C., and Ozturk, M. (2006). Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol. Rep. 15, 701-707   PUBMED
7 Chen, W., Salto-Tellez, M., Palanisamy, N., et al. (2007). Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes Chromo. Cancer 46, 288-301   DOI   ScienceOn
8 Eisen, S.F., and Brown, H.A. (2002). Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-Negative breast cancer cells. Mol. Pharmacol. 62, 911-920   DOI   ScienceOn
9 Hollestelle, A., Elstrodt, F., Nagel, J.H., Kallemeijn, W.W., and Schutte, M. (2007). Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol. Cancer Res. 5, 195-201   DOI   ScienceOn
10 Reubi, J.C. (2003). Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 24, 389-427   DOI   PUBMED   ScienceOn
11 Kulka, J., Szasz, A.M., Nemeth, Z., Madaras, L., Schaff, Z., Molnar, I.A., and Tokes, A.M. (2009). Expression of Tight Junction Protein Claudin-4 in Basal-Like Breast Carcinomas. Pathol. Oncol. Res. 15, 59-64   DOI   ScienceOn
12 Greco, S., Elia, M.G., Muscella, A., Romano, S., Storelli, C., and Marsigliante, S. (2005). Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J. Endocrinol. 186, 291-301   DOI   ScienceOn
13 Aggarwal, S., and Gurney, A.L. (2002). IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71, 1-8   PUBMED
14 Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S.N., Barrera, J.L., Mohar, A., Verástegul, E., and Zlotnik, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56   DOI   ScienceOn
15 Venter, D.J., Ramus, S.J., Hammet, F.M., de Silva, M., Hutchins, A.M., Petrovic, V., Price, G., and Armes, J.E. (2005). Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines. Cancer Genet. Cytogenet. 160, 134-140   DOI   ScienceOn
16 Flanagan, J.M., Munoz-Alegre, M., Henderson, S., et al. (2009). Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum. Mol. Genet. 18, 1332-1342   DOI   ScienceOn
17 Hill, J.J., Tremblay, T.L., Cantin, C., O'Connor-McCourt, M., Kelly, J.F. and Lenferink, A.E. (2009). Glycoproteomic analysis of two mouse mammary cell lines during transforming growth factor (TGF)-$\beta$ induced epithelial to mesenchymal transition. Proteome Sci. 7, 2   DOI   ScienceOn
18 Campo, L., Turley, H., Han, C., Pezzella, F., Gatter, K.C., Harris, A.L., and Fox, S.B. (2005). Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. J. Pathol. 205, 585-591   DOI   ScienceOn
19 Pentecost, B.T. (1998). Expression and estrogen regulation of the HEM45 mRNA in human tumor lines and in the rat uterus. J. Steroid Biochem. Mol. Biol. 64, 25-33   DOI   PUBMED   ScienceOn
20 Bin Amer, S.M., Maqbool, Z., Nirmal, M.S., Qattan, A.T., Hussain, S.S., Jeprel, H.A., Tulbah, A.M., Malik, O.A., and Al-Tweigeri, T.A. (2008). Gene expression profiling in women with breast cancer in a Saudi population. Saudi Med . J. 29, 507-513   PUBMED
21 Han, C.Z., Du, L.L., Jing, J.X., Zhao, X.W., Tian, F.G., Shi, J., Tian, B.G., Liu, X.Y., and Zhang, L.J. (2008). Associations among lipids, leptin, and leptin receptor gene Gin223Arg polymorphisms and breast cancer in China. Biol. Trace. Elem. Res. 126, 38-48   DOI   ScienceOn
22 Salaun, B., Coste, I., Rissoan, M.C., Lebecque, S.J., and Renno, T. (2006). TLR3 can directly trigger apoptosis in human cancer cells. J. Immunol. 176, 4894-4901   DOI
23 Ashburner, M., Ball, C.A., Blake, J.A., et al. (2000). Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25-29   DOI   ScienceOn
24 Rody, A., Holtrich, U., Gaetje, R., Gehrmann, M., Engels, K., von Minckwitz, G., Loibl, S., Diallo-Danebrock, R., Ruckhäberle, E., Metzler, D., Ahr, A., Solbach, C., Karn, T., and Kaufmann, M. (2007). Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. Clin. Cancer Res. 13, 1115-1122   DOI   ScienceOn
25 Zhou, P., Zhi, X., Zhou, T., Chen, S., Li, X., Wang, L., Yin, L., Shao, Z., and Ou, Z. (2007). Overexpression of Ecto-5'-Nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Cancer Biol. Ther. 6, 426-431   DOI
26 Turashvili, G.., Bouchal, J., Baumforth, K., Wei, W., et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microsection and microarray analysis. BMC Cancer 7, 55   DOI   PUBMED
27 Lane, J., Martin, T.A., Mansel, R.E., and Jiang, W.G. (2008). The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer. Int. Semin . Surg. Oncol. 5, 23.   DOI   ScienceOn
28 Goodale, D., Phay, C., Brown, W., Gray-Statchuk, L., Furlong, P., Lock, M., Chin-Yee, I., Keeney, M., and Allan, A.L. (2009). Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer. Cytometry B Clin. Cytom. 76, 107-117   DOI   ScienceOn
29 Hassan, M.I., Waheed, A., Yadav, S., Singh, T.P., and Ahmad, F. (2009). Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications. Cell. Mol. Life Sci. 66, 447-459   DOI   ScienceOn
30 Lin, X., Duan, X., Liang, Y.Y., Su, Y., et al. (2006). PPM1A Functions as a Smad Phosphatase to Terminate TGF $\beta$ Signaling. Cell 125, 915-928   DOI   PUBMED   ScienceOn
31 Lee, S.W., Reimer, C.L., Fang, L., Iruela-Arispe, M.L., and Aaronson, S.A. (2000). Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol. Cell Biol. 20, 1723-1732   DOI   ScienceOn
32 Han, G., Fan, B., Zhang, Y., Zhou, X., Wang, Y., Dong, H., Wei, Y., Sun, S., Hu, M., Zhang, J., and Wei, L. (2008). Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells. Oncol. Rep. 20, 929-938   PUBMED
33 Rouvier, E., Luciani, M.F., Mattei, M.G., Denizot, F., and Golstein, P. (1993). CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150, 5445-5456
34 Williams, K.J., Cowen, R.L., and Stratford, I.J. (2001). Hypoxia and oxidative stress in breast cancer: Tumour hypoxia - herapeutic considerations. Breast Cancer Res. 3, 328-331   DOI   ScienceOn
35 Qiu, X., Zhu, X., Zhang, L., Mao, Y., et al. (2003). Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 63, 6488-6495   PUBMED
36 Kabbage, M., Chahed, K., Hamrita, B., Guillier, C.L., Trimeche, M., Remadi, S., Hoebeke, J., and Chouchane, L. (2008). Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry. J. Biomed. Biotechnol. 2008, 564127   DOI
37 Derevianko, A., Graeber, T., D'Amico, R., and Simms, H.H. (1996). Altered oxygen tension modulates cytokine-induced signal transduction in polymorphonuclear leukocytes: regulation of the GPLD pathway. Shock 2, 97-105   DOI
38 Naderi, A., Teschendorff, A.E., Barbosa-Morais, N.L., et al. (2007). A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26, 1507-1516   DOI   ScienceOn
39 Murabito, J.M., Rosenberg, C.L., Finger, D., Kreger, B.E., Levy, D., Splansky, G.L., Antman, K., and Hwang, S.J. (2007). A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med. Genet. 8(Suppl 1), S6   DOI   PUBMED
40 Danasekaran, S.M., Barrette, T.R., Ghosh, D., et al. (2001). Delineation of prognostic biomarkers in prostate cancer metastasis. Nature 412, 822-826   DOI   ScienceOn
41 Dorsam, R.T., and Gutkind, J.S. (2007). G-protein-coupled receptors and cancer. Nat. Rev. Cancer 7, 79-94   DOI   ScienceOn
42 Pennanen, P.T., Sarvilinna, N.S., Purmonen, S.R., and Ylikomi, T.J. (2009). Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models. Steroids 74, 404-409   DOI   ScienceOn
43 Sennino, B., Kuhnert, F., Tabruyn, S.P., Mancuso, M.R., Hu-Lowe, D.D., Kuo, C.J., and McDonald, D.M. (2009). Cellular Source and Amount of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Tumors Determine Response to Angiogenesis Inhibitors. Cancer Res. 69, 4527   DOI   ScienceOn
44 Fuja, T.J., Lin, F., Osann, K.E., and Bryant, P.J. (2004). Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon, DLG1, and EDD/hHYD in mammary ductal carcinoma. Cancer Res. 64, 942-951   DOI   PUBMED   ScienceOn
45 Naor, Z. (2009). Signaling by G-protein-coupled receptor (GPCR): Studies on the GnRH receptor. Front. Neuroendocrinol. 30, 10-29   DOI   PUBMED   ScienceOn